Joshua is a PhD (Medicine) candidate at the South Australian Immunogenomics Cancer Institute (SAiGENCI) at the University of Adelaide in the Prostate Cancer Research Group lead by Prof. Lisa Butler. Josh's Research involves the discovery of companion biomarkers and resistance mechanisms to current and emerging prostate cancer therapeutics to improve clinical decision making and patient treatment.